Author

Miguel Brito

Escola Superior de Tecnologia da Sa

Biography

Biography Centro de Investigação de Montanha (CIMO) Escola Superior Agrária de Ponte de Lima Instituto Politécnico de Viana do Castelo Miguel Brito works as a assistant professor at Lisbon School of Health Technology, Polytechnic Institute of Lisbon, Portugal
Title
Cited by
Year
Prevalence of major and minor electrocardiographic abnormalities and their relationship with cardiovascular risk factors in Angolans
MAA Gonçalves, JM Pedro, C Silva, P Magalhães, M BritoIJC Heart & Vasculature 39, 100965, 2022202
7
2022
Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus aureus
AS Zeferino, AR Mira, M Delgadinho, M Brito, T Ponte, E RibeiroCurrent Microbiology 9 (5), 149, 2022202
7
2022
Helminth infections and allergic diseases: Systematic review and meta-analysis of the global literature
M Arrais, T Maricoto, BI Nwaru, PJ Cooper, JMR Gama, M Brito, ...Journal of Allergy and Clinical Immunology 149 (6), 2139-2152, 2022202
7
2022
Depressive symptomatology, temperament and oxytocin serum levels in a sample of healthy female university students
L Veiga, E Carolino, I Santos, C Veríssimo, A Almeida, A Grilo, M Brito, ...BMC psychology 10 (1), 1-9, 2022202
5
2022
5
2022
Dengue virus among HIV-infected pregnant women attending antenatal care in Luanda, Angola: An emerging public health concern
CS Sebastião, Z Neto, D Jandondo, M Mirandela, J Morais, M BritoScientific African 17, e01356, 2022202
4
2022
Predictors of low quality of life after open inguinal hernia repair using the EuraHS-QoL score: prospective multicentric cohort study across 33 hospitals
Predictors of low quality of life after open inguinal hernia repair using the EuraHS-QoL score: prospective multicentric cohort study across hospitalsHernia 26 (1), 225-22, 2022202
3
2022
Epigenetic and transcriptional modulator potential of epigallocatechin-3-gallate and genistein on fetal hemoglobin reactivators genes
Epigenetic and transcriptional modulator potential of epigallocatechin--gallate and genistein on fetal hemoglobin reactivators genesE Ribeiro, M Delgadinho, E Matos, R Santos, D Sousa, H Galante, M BritoClinical Complementary Medicine and Pharmacology 2 (2), 10004, 2022202
3
2022
Prevalence of atrial fibrillation in Bengo Province, Angola: Results from a population-based study
M Gonçalves, J Pedro, C Silva, P Magalhães, M BritoRevSALUS-Revista Científica Internacional da Rede Académica das Ciências da …, 010
2
2021
Microbial gut evaluation in an angolan paediatric population with sickle cell disease
M Delgadinho, C Ginete, B Santos, J Mendes, A Miranda, J Vasconcelos, ...Journal of Cellular and Molecular Medicine 6 (1), 5360-5368, 0
2
2022
How hydroxyurea alters the gut microbiome: a longitudinal study involving angolan children with sickle cell anemia
M Delgadinho, C Ginete, B Santos, C Fernandes, C Silva, A Miranda, ...International Journal of Molecular Sciences 23 (6), 906, 2022202
1
2022
Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
Clinical features related to severity and mortality among COVID-9 patients in a pre-vaccine period in Luanda, AngolaCS Sebastião, A Cogle, ADA Teixeira, AM Cândido, C Tchoni, MJ Amorim, ...Tropical Medicine and Infectious Disease 7 (), 338, 2022202
1
2022
Gut microbiota profile of COVID-19 patients: Prognosis and risk stratification (MicroCOVID-19 study)
Gut microbiota profile of COVID-9 patients: Prognosis and risk stratification (MicroCOVID-9 study)JG Nobre, M Delgadinho, C Silva, J Mendes, V Mateus, E Ribeiro, ...Frontiers in Microbiology 3, 035422, 2022202
1
2022
DNA methyltransferase expression (DNMT1, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema response
DNA methyltransferase expression (DNMT, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema responseP Camacho, E Ribeiro, B Pereira, T Varandas, J Nascimento, J Henriques, ...European Journal of Ophthalmology, 20672237623, 2023202
1
2023